Distinguished Scientist
Merck & Co., Inc.
Rahway, New Jersey
Filippos Kesisoglou is a Distinguished Scientist at Merck & Co., Inc., (Rahway, NJ) where he is currently leading the Biopharmaceutics efforts in the Pharmaceutical Sciences department. Filippos has more than 19 years of experience in the fields of biopharmaceutics and formulation development, pharmacokinetics, PBPK and IVIVC modeling as related to clinical, drug product development and CMC regulatory applications across small molecule and oral peptides, long acting injectables and biologics modalities He has been a key contributor to several new drug applications. He has authored/co-authored more than 90 manuscripts/book chapters and more than 90 conference abstracts/podium presentations in several national/international meetings in the fields of biopharmaceutics, PBPK modeling, formulation development and drug delivery. Filippos has been involved over the years in several cross-industry and academia consortia and since 2023 has joined the ICH M13 Expert Working Group. He is currently serving as an Editor for Journal of Pharmaceutical Sciences and on the Editorial Advisory Board for the AAPS Journal and Pharmaceutical Research. Filippos has been an active member of AAPS over the years and in 2017 he was elected as an AAPS Fellow.
Disclosure information not submitted.
Interesting Biopharmaceutics Questions from Development of an Oral Macrocyclic Peptide
Monday, October 21, 2024
3:50 PM – 4:10 PM MT
Hot Topic: Trends in Utility of Animal Studies in Oral Drug Development
Wednesday, October 23, 2024
3:00 PM – 4:00 PM MT